[go: up one dir, main page]

FI19992609L - Uusi koostumus - Google Patents

Uusi koostumus

Info

Publication number
FI19992609L
FI19992609L FI992609A FI19992609A FI19992609L FI 19992609 L FI19992609 L FI 19992609L FI 992609 A FI992609 A FI 992609A FI 19992609 A FI19992609 A FI 19992609A FI 19992609 L FI19992609 L FI 19992609L
Authority
FI
Finland
Prior art keywords
new composition
composition
new
Prior art date
Application number
FI992609A
Other languages
English (en)
Swedish (sv)
Other versions
FI19992609A7 (fi
Inventor
David Philip Elder
Ghazawi Ahmad Khalaf Al
Meneaud Padma Patel
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9914601.1A external-priority patent/GB9914601D0/en
Priority claimed from GBGB9914709.2A external-priority patent/GB9914709D0/en
Priority claimed from GBGB9927501.8A external-priority patent/GB9927501D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of FI19992609A7 publication Critical patent/FI19992609A7/fi
Publication of FI19992609L publication Critical patent/FI19992609L/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI992609A 1999-06-22 1999-12-03 Uusi koostumus FI19992609L (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9914601.1A GB9914601D0 (en) 1999-06-22 1999-06-22 Composition
GBGB9914709.2A GB9914709D0 (en) 1999-06-23 1999-06-23 Composition
GBGB9927501.8A GB9927501D0 (en) 1999-11-19 1999-11-19 Composition

Publications (2)

Publication Number Publication Date
FI19992609A7 FI19992609A7 (fi) 2000-12-22
FI19992609L true FI19992609L (fi) 2000-12-22

Family

ID=27269749

Family Applications (2)

Application Number Title Priority Date Filing Date
FI990494U FI4488U1 (fi) 1999-06-22 1999-12-03 Farmaseuttinen koostumus
FI992609A FI19992609L (fi) 1999-06-22 1999-12-03 Uusi koostumus

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FI990494U FI4488U1 (fi) 1999-06-22 1999-12-03 Farmaseuttinen koostumus

Country Status (21)

Country Link
EP (1) EP1064936A1 (fi)
AT (1) AT3722U1 (fi)
AU (2) AU1573100A (fi)
BE (2) BE1013166A6 (fi)
CA (1) CA2291542A1 (fi)
CH (1) CH690024A5 (fi)
DE (2) DE19958228A1 (fi)
DK (2) DK199900435U3 (fi)
ES (1) ES2159260B1 (fi)
FI (2) FI4488U1 (fi)
FR (1) FR2795327A1 (fi)
GB (1) GB2351233A (fi)
GR (1) GR1003490B (fi)
IE (2) IES991108A2 (fi)
IT (1) ITMI992549A1 (fi)
LU (1) LU90483B1 (fi)
NL (2) NL1013750C1 (fi)
NO (1) NO995945L (fi)
PT (1) PT102384A (fi)
SE (1) SE9904404L (fi)
WO (1) WO2000078291A1 (fi)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
GB0003232D0 (en) * 2000-02-11 2000-04-05 Smithkline Beecham Plc Novel composition
IL154422A0 (en) * 2000-08-28 2003-09-17 Synthon Bv Paroxetine compositions and processes for making the same
US6921839B2 (en) 2000-08-29 2005-07-26 Ranbaxy Laboratories Limited Synthesis of N,N-dimethyl-3-(4-methyl) benzoyl propionamide a key intermediate of zolpidem
DE20100529U1 (de) * 2001-01-11 2001-05-10 Synthon Bv Pharmazeutische Tablette umfassend Paroxetinmesylat
CA2361882A1 (en) * 2001-10-19 2003-04-19 Bernard Charles Sherman Liquid for oral administration comprising paroxetine
JP2005517690A (ja) 2002-02-01 2005-06-16 ファイザー・プロダクツ・インク 固体薬物分散物を含有する即時放出剤形
WO2005010002A1 (en) * 2003-07-31 2005-02-03 Ranbaxy Laboratories Limited Process for the synthesis of zolpidem
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine
CN105963273A (zh) * 2016-05-02 2016-09-28 杭州富阳伟文环保科技有限公司 甲磺酸帕罗西汀胶囊及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5371092A (en) * 1990-11-24 1994-12-06 Beecham Group, P.L.C. Use of paroxetine for the treatment of senile dementia, bulimia, migraine or anorexia
GB9514842D0 (en) * 1995-07-20 1995-09-20 Smithkline Beecham Plc Novel formulation
GB9605828D0 (en) * 1996-03-20 1996-05-22 Smithkline Beecham Plc Treatment method
ATE200781T1 (de) * 1997-06-10 2001-05-15 Synthon Bv 4-phenylpiperidin-derivate
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.

Also Published As

Publication number Publication date
LU90483B1 (fr) 2001-01-31
IE991107A1 (en) 2001-05-30
BE1013166A6 (fr) 2001-10-02
DK199901730A (da) 2000-12-23
NL1013749C2 (nl) 2001-01-08
EP1064936A1 (en) 2001-01-03
FI4488U1 (fi) 2000-07-20
ITMI992549A1 (it) 2001-06-03
GB2351233A (en) 2000-12-27
NL1013750C1 (nl) 2000-12-28
CA2291542A1 (en) 2000-12-22
NO995945D0 (no) 1999-12-03
ES2159260B1 (es) 2002-05-01
ES2159260A1 (es) 2001-09-16
AT3722U1 (de) 2000-07-25
GR1003490B (el) 2000-11-30
DK199900435U3 (da) 2000-02-11
FI19992609A7 (fi) 2000-12-22
AU1573100A (en) 2001-01-09
FR2795327A1 (fr) 2000-12-29
SE9904404L (sv) 2000-12-23
AU727000B3 (en) 2000-11-30
BE1012806A3 (fr) 2001-03-06
DE29921300U1 (de) 2000-02-10
SE9904404D0 (sv) 1999-12-03
GB9928673D0 (en) 2000-02-02
IES991108A2 (en) 2001-04-04
DE19958228A1 (de) 2000-12-28
NO995945L (no) 2000-12-27
PT102384A (pt) 2000-12-29
ITMI992549A0 (it) 1999-12-03
CH690024A5 (fr) 2000-03-31
WO2000078291A1 (en) 2000-12-28
FIU990494U0 (fi) 1999-12-03

Similar Documents

Publication Publication Date Title
IS6120A (is) Lyfjablanda
NO20021116D0 (no) Ny sammensetning
AR023440A1 (es) Composiciones antitranspirantes
IS6024A (is) Ný efnasambönd
ID26186A (id) Komposisi sampo
ID28694A (id) Komposisi sampo
PT1202994E (pt) Novos compostos
ID29430A (id) Komposisi herbisida
NO20021115D0 (no) Ny sammensetning
ID29785A (id) Komposisi-komposisi sampo
ATE257691T1 (de) Schweisshemmende zusammensetzungen
DE69928862D1 (de) Zusammensetzung
DE69942892D1 (de) Gaserzeugende zusammensetzung
IS6139A (is) Ný efnasambönd
DE69943245D1 (de) Gaserzeugende zusammensetzung
FI19992609L (fi) Uusi koostumus
IS6141A (is) Ný efnasambönd
DE60020682D1 (de) Resorcinenthaltende zusammensetzung
ID26295A (id) Komposisi keras-ultraviolet
ID27329A (id) Komposisi penghambat
ID26485A (id) Komposisi paroksetina
ID28359A (id) Komposisi
NO20022845D0 (no) Limsammensetning
ID30320A (id) Komposisi-komposisi berpigmen
DE60029780D1 (de) Biozide zusammensetzungen